Oxford BioDynamics Company Description

Oxford BioDynamics Plc, together with its subsidiaries, operates as a biotechnology company that y developing, and commercializing precision medicine tests for life-changing diseases in the United States and the United Kingdom.

The company provides EpiSwitch CiRT (Checkpoint inhibitor Response Test), a blood test that predicts an individual patient's therapeutic response to checkpoint inhibitor immunotherapy.

EpiSwitch, a proprietary technology platform that enables screening, evaluation, validation and monitoring of 3D genomic biomarker.

Its products include EpiSwitch Prostate Screening Test (PSE), a prostate cancer screening test; EpiSwitch CiRT (Checkpoint Inhibitor Response Test), a blood test for predicting therapeutic response to checkpoint inhibitor immunotherapy; EpiSwitch Orion, a cloud platform, running on google cloud architecture; and EpiSwitch Explorer Array Kit platform, enabling advanced analysis of 3D regulatory control points.

The company was incorporated in 2007 and is headquartered in Oxford, the United Kingdom.

Oxford BioDynamics Plc

Country	United Kingdom
Founded	2007
Industry	Diagnostics & Research
Sector	Healthcare
Employees	41

Contact Details

Address: 3140 Rowan Place Oxford, OX4 2WB United Kingdom
Phone	44 1865 518 910
Website	oxfordbiodynamics.com

Stock Details

Ticker Symbol	OXBOF
Exchange	OTCMKTS
Fiscal Year	October - September
Reporting Currency	GBP
ISIN Number	GB00BD5H8572
SIC Code	2835

Key Executives

Name	Position
Iain Gladstone Ross B.Sc., BSc (Hons), C.DIR, CH.D	Executive Chairman
Paul Leslie Stockdale F.C.A., M.A.	Chief Financial Officer and Executive Director
Dr. Alexandre Akoulitchev M.A., Ma (Oxon), Ph.D.	Chief Scientific Officer and Executive Director
Thomas G. Guiel B.A.	Chief Operating Officer
David Blum	Senior Vice President of Marketing
Dr. Ewan Hunter B.Sc., Ph.D., Ph.D., (KCL)	Chief Data Officer
T. Demain	Company Secretary